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It has been reported recently that one can demonstrate synergy among populations 
of parental lymphoid cells in the elicitatlon of graft-versus-host  (GVH)  1 reactions in 
normal neonatal F1 recipient mice (1-3). Using the quantitative spleen weight assay 
(4)  as a  measure of  GVFI activity, it was  found that mixtures of either peripheral 
blood leukocytes (PBL)  or femoral lymph node cells and thymocytes gave reactions 
in excess of those expected by summing the reactivities of these populations measured 
separately. 
It is well established that much of the splenomegaly seen in animals undergoing a 
GVH reaction is due to immunologically nonspecific proliferation of host cells (5-8). 
Barchilon and  Gershon  (9)  and Hilgard (10)  have  reported examples in irradiated 
recipients in which immunologically unreactive cells, such as syngeneic bone marrow, 
produce increased splenomegaly when combined with allogeneic cells. It was unlikely 
that such a mechanism was responsible for the synergy observed in the present model 
employing normal F1 recipients, since synergy was  never observed when either the 
allogeneic PBL or thymocytes were replaced either by a11ogeneic bone marrow or by 
appropriate cells syngeneic with the host (1-3). 
Nevertheless, it seemed desirable to attempt to demonstrate this synergy utilizing 
a  GVH  assay system  which  should not  depend on  those  nonspecific factors which 
contribute to splenomegaly (11). A mortality assay was chosen for two reasons. First, 
from the studies of Owens and Santos (12) it appeared that one could readily quantitate 
differences in the lethality of various cell populations and thereby facilitate a demon- 
stration of synergy, if indeed it occurred.  Secondly, the  studies of Biltingham and 
Silvers (13) and Cantor et al. (14) suggested that the capacity of some tissues to cause 
lethal runting seemed out of proportion to their capacity to cause splenomegaly. 
The  results presented in this paper indicate (a)  that synergy between PBL 
and  thymocytes  can  be  demonstrated  using  a  mortality assay as  a  measure 
of the GVH reaction, and (b) that the kinetics of cumulative mortMity induced 
by  appropriate mixtures  of  PBL  and  thymocytes  are  indistinguishable  from 
1  Abbreviations used in this paper: GVH,  graft-~ersus-host; HBSS, Hanks' balanced salt 
solution; PBL, peripheral blood leukocytes. 
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those  induced by large numbers of  thymocytes alone and are  different from 
those  produced  by  PBL.  Analysis of  the  relative capacities of  different  cell 
populations to cause lethal runting on the one hand and  splenomegaly on the 
other suggests that different cells may in fact be responsible for initiating these 
different effector activities. 
Materials and Methods 
Animals.--Adult (8-16 wk old) male B.~LB/cAnN  (H-2  d) mice  and 1-5 day old litters  of 
F1 hybrid C57BL/6N  by BALB/cAnN  (H-2b/H-2  d) mice were obtained from the Rodent 
and Rabbit Production Section, Division of Research Services, National Institutes of Health, 
Bethesda, Md. 
Irradiation.--Recipient F1 mice placed in a Lucite box were exposed to 400 R total body 
irradiation 1-3 hr before inoculating them with cells. A Westinghouse Quadrocondex 250 kvp 
machine was used under conditions of 200 kvp, 15 ma, half-value layer 0.9 mm of Cu, at a 
distance of 54 cm, and an administered dose rate of 139 R/rain. 
Cell Suspensions.--Groups of animals were killed by exsanguination from  the  axillary 
vessels under ether anesthesia. Suspensions of femoral lymph node, spleen, and thymus cells 
were prepared by gently teasing the tissue apart and washing the cells once in Hanks' balanced 
salt solution (HBSS, Grand Island Biological  Co., Grand Island, N. Y.). Care was taken when 
removing the thymus to avoid both contamination with blood and accidental inclusion of 
parathymic lymph nodes. Peripheral blood was collected by bleeding from the axillary vessels 
into pipettes rinsed with heparin (1 mg/ml) ; PBL were obtained as described by Wilson (15). 
Cells were resuspended in HBSS to the desired concentration of nucleated cells; when combina- 
tions of cells were to be used, appropriate  concentrations were mixed together immediately 
before injection. 
Graft-Versus-Host Assay.--Within 3 hr of irradiation, F1 recipients, 1-5 days old, were in- 
jected intraperitoneally with a constant volume of 0.05 ml of the desired suspension of parental 
and/or syngenelc cells; injections were made via a 30-gauge hypodermic needle introduced 
subcutaneously along the medial aspect of the  thigh in order to avoid leakage. Mice were 
counted daily for the first 35 days and then twice weekly for an additional month. Since the 
majority of deaths among uninjected irradiated mice occurred within the 1st week of observa- 
tion and since  very few recipients of allogeneic cells died after 35 days (see Results), analysis 
of mortality between days 7 and 35 was used to measure GVH activity. Cumulative mortality 
was calculated as the percentage of mice dead relative to the number alive on day 7. 
RESULTS 
Comparison  of Normal and Irradiated Recipients.--An initial experiment was 
designed to compare the mortality of normal and sublethally irradiated (400 R) 
F1 recipients of BALB/c spleen cells (Fig. 1).  10 or 25  X  106 spleen cells in- 
jected into normal F1 recipients produced comparable and rather low levels of 
mortality. When the F1 recipients were pretreated with 400 R, 5 and 10 X  106 
spleen cells produced 35  day  cumulative mortalities of  55  and 90%,  respec- 
tively. Thus, irradiation resulted in at least a threefold increase in the sensitivity 
of F1 recipients to lethal GVH reactions. All subsequent experiments utilized 
irradiated recipients. 
The observation period for this experiment was about 60 days. It was found 
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not exceed the 35 day mortality by more than 10%; therefore, for convenience 
the data shown extend only through 39 days. 
The validity of discounting any deaths occurring within  the  1st week after 
inoculation of cells was established throughout the course of this study. Deaths 
among irradiated  control mice which received no cells usually occurred within 
this 1st week of observation; of the 255 such control animals, 29 (11.4%)  died 
at some time during the 60 day observation period,  and 20 (8 %)  died within 
the 1st week. The majority of these early deaths occurred in a small number of 
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FIO. 1. The effect of sublethal  irradiation  of F1 recipients of parental  strain  cells on ob- 
served cumulative  mortality.  (a)  Groups of 30 normal  C57BL/6 X  BALB/c F1 neonates, 
1-5 days old, were inoculated with either  107 (0) or 2.5 X 107 (B) adult BALB/c spleen cells. 
Recipients were observed for 2 months; for convenience the data shown extend only from day 
7 through day 39  (see text).  Percentage  mortality was calculated  as  the cumulative  per- 
centage of mice dead relative  to the number alive on day 7.  (b) F1 recipients of 5.0 X  10  ~ 
(A) or 10  ~ (©) BALB/c spleen cells were exposed to 400 R whole body irradiation  1-3 hr 
before inoculation of cells. Mortality among uninjected  irradiated  mice during the observa- 
tion period  was approximately  11%  (see text)  and does not differ significantly from the 
mortality observed among uninjected normal mice of this strain. 
litters and were directly attributable  either to cannibalism by the mother or to 
her failure  to nurse  the  litter.  In all  the  experiments  reported  in  this paper 
(nearly 1000 recipients),  the early (1-7 day) mortality of irradiated  recipients 
of parental  cells  was also  8%,  and  again  the  majority  of deaths  occurred in 
very few litters, for the same reasons as in controls, and could not be correlated 
with the size or origin of the cell inoculum. 
Comparison of Various Doses of Thymocytes, PBL, and Femoral Lymph Node 
Cells.--The  results  of injecting  different  numbers  of parental  thymocytes or 
PBL into irradiated F1 neonates are shown in Fig. 2. The mortalities shown are 
the means of at least three  separate  experiments  at each particular inoculum. 
Increasing the number of inoculated cells increased the observed 35 day mor- 1062  SYNERGY  IN  A  GVH  MORTALITY  ASSAY 
tality.  1  X  10 G  PBL caused a  35  day mortality of approximately 80%; com- 
parable levels of mortality were seen with 25  X  106 thymocytes. In addition 
to showing the obvious quantitative differences between the lethality of PBL 
and  thymocytes, Fig.  2  also  reveals an  interesting  qualitative  difference be- 
tween these tissues. If one arbitrarily chooses a day midway in the assay, such 
as day 21,  one can see that well over half of the recipients of any given inocu- 
lum of PBL which will ultimately succumb are already dead by this time. On 
the  other  hand,  relatively  few  of  the  recipients  of  thymocytes  which  ulti- 
mately died had done so by day 21. For any given level of mortality, recipients 
of thymocytes survived approximately a  week longer than recipients of PBL. 
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FIG. 2.  Comparison of effects on observed cumulative  mortality  among irradiated  F1 
recipients of various numbers of adult BALB/c peripheral blood leukocytes (PBL) or thymo- 
cytes. (a) Irradiated recipients  were inoculated with 2.5 X 105 (&), 5.0 X 105 (m), or 1.0 X 106 
(e) PBL.  (b) Irradiated  recipients were inoculated with 1.0 X  107 (A), 1.5 X  107 (K]), or 
2.5 X  107 (O) thymocytes. Mortalities shown are the means of at least three separate experi- 
ments (60-100 recipients) at each inoculum. 
Thus,  in  addition  to  being  quantitatively  more  effective than  thymocytes, 
PBL also tended to cause significantly earlier mortality than did equivalently 
lethal numbers of thymocytes. 
Similar experiments were carried out employing different numbers of BALB/c 
femoral lymph node cells. The 35 day mortality induced by 1.5 X  10 G, 1.0 X  106, 
and 5.0 X  105 lymph node cells was 84, 67, and 30%, respectively. In addition, 
the mortality produced by these cells occurred relatively early, as was the case 
with PBL, i.e., animals began dying in significant numbers late in the 2nd week 
of observation. 
In order to quantitate the differences in lethality of cells obtained from these 
various tissues,  the percentages of 35  day mortalities were plotted on a probit ROBERT  E.  TIGELAAR  AND  RICHARD  ASOFSKY  1063 
scale  as  a  function  of numbers  of cells  injected  as plotted  on  a  logarithmic 
scale.  These  results  are  shown  in  Fig.  3.  A  linear  relationship  between  the 
probit of the per cent of mortality and the logarithm of the number of inocu- 
lated cells was observed for each of the tissues tested. In addition it can be seen 
that  the reactivity curves for each tissue form parallel  lines with  each  other, 
thus permitting a  quantitative  comparison of the reactivities  of the cell popu- 
lations. The regression lines shown in Fig. 3 were estimated visually. However, 
the slopes of the regression lines for different cell populations calculated by the 
method  of least  squares were not significantly different from each other,  i.e., 
P  >  0.5. PBL, which were the most lethal cell population, were about 30 times 
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FIG. 3. Comparison of the 35 day cumulative per cent of mortality among irradiated  F, 
recipients of graded numbers of BALB/c PBL (.), femoral lymph node (V), spleen (A), or 
thymus cells (0). The 35 day per cent of mortalities are plotted on a probit scale as a func- 
tion of the logarithm of the cell inoculum. The slopes of each of the regression lines calculated 
by the method of least squares were not significantly different from each other, i.e., P  >  0.5. 
as active as thymocytes, while femoral lymph node cells and spleen cells were 
slightly more than 20 and 3 times as reactive as thymocytes, respectively. 
Activity of Combinations of PBL and  Thymocytes.--Experiments  were  next 
performed  to examine  the  lethality  of combinations of PBL  and  thymocytes 
injected  together.  When  10  X  106  thymocytes were  injected  together  with 
2.0  X  105 PBL  into  a  group of 30  F1  mice,  the  35  day mortality  was  82 % 
(Fig. 4). By reference to Fig. 3, one can calculate that 2.0 X  105 PBL are the 
equivalent of 6.0 X  106 thymocytes. If the reactivities of PBL and thymocytes 
combined were simply additive, i.e. the sum of their reactivities measured sepa- 
rately, one would have expected to see a 35 day mortality equivalent to that of 
approximately 16  X  106 thymocytes, or about 60%. The observed activity of 
82%,  however,  is  equivalent  to  the  reactivity  of  25  X  106  thymocytes,  or 
about 1.6 times the expected reactivity. 1064  SYNERGY LN A  GVIt  MORTALITY ASSAY 
The mortality as a function of time observed when mice were injected with 
10 X  106 thymocytes combined with 1.0 X  105 PBL is also illustrated in Fig. 4 
and represents  the mean of four separate experiments involving approximately 
90 recipient mice. The observed 35 day mortality of nearly 80 % is again equiva- 
lent to that seen with 25 X  106 thymocytes alone, while the expected reactivity 
of this combination of cells if the activities  were merely additive was that of 
80 
J 
<60 
o 
4o 
o_ 
20 
0 
107T + 2xlO 5 PZ 
o,~/° 
//  ,' 
I/  // 
I  I  I  I  i  I  I  I  I  I  ,  I  ,  I 
II  1,5  19  23  27  31  35 
DAYS 
Fro. 4. Cumulative  mortality among irradiated  F1 recipients of combinations of BALB/c 
PBL and thymocytes.  A group of 30 recipients was each inoculated with a  mixture  of  107 
thymocytes (T) and 2.0 X  105 PBL (0). The mortalities shown for recipients of mixtures of 
107 thymocytes and 1.0 X  105 PBL (©) represent  the means of four separate experiments 
(90 recipients). The mortality observed with 1.5 X  107 thymocytes alone (Fig. 2) is shown as 
a reference. 
approximately 13  X  106 thymocytes. In this case the observed reactivity was 
nearly twice  the  expected  reactivity. 
The kinetics of the mortality curves obtained with combinations of PBL and 
thymocytes which gave synergistic levels of 35  day mortality  (Fig. 4)  are in- 
distinguishable  from  those  seen  with  a  large  inoculum  of  thymocytes  alone 
(Fig.  2).  Animals did not die  in significant numbers  until  the  end  of the 3rd 
week, with the majority of deaths occurring within the next several days. 
Requirement for Allogeneic Cells to Observe Synergy.--In  the previous studies 
using  the  spleen  weight  assay  it  was found  that  no  synergy was  observed  if 
either the parental strain PBL or thymocytes in the combination were replaced ROBERT  E.  TIGELAAR AND  RICHARD  ASOFSKY  1065 
by  F1  cells,  indicating  that  both  populations  had  to  have  the  capacity  to 
specifically recognize foreign antigens in the F1 recipients. Similar experiments 
were  designed  to  determine  whether  the  synergy observed in  the  mortality 
assay also required that both populations be allogeneic. 
Inoculation of either 1.5  X  106 F1 PBL or 35  X  106 F~ thymocytes into ir- 
radiated F1 recipients produced mortality identical to that seen among control 
animals receiving no cells. Animals inoculated with a combination of 10 ;K 106 FI 
thymocytes and 1.0 X  105 BALB/c PBL also showed control levels of mortality 
at 60 days. The reverse combination, that is,  10  ;K  106 BALB/c thymocytes 
and 1.0  X  105 F~ PBL, produced a 35 day mortality of 32 %, identical to that 
observed  in  recipients  of  l0  X  106  BALB/c  thymocytes  alone.  Therefore, 
TABLE  I 
Comparison of Relative Readivities of Cell Populations in  the Mortality Assay with Their 
Reactivities in the Spleen Weight Assay 
Cell source 
Parallel line method  Limiting dilution method 
Mortality  Spleen weight  Mortality  Spleen weight 
assay  assay  assay  assay 
Femoral lymph node  22.7  14.6  25.9  15.0 
PBL  31.3  25.0  35.0  20.0 
Spleen  3.3  7.6  2.9  6.0 
The reactivity of thymocytes was assigned an arbitrary value of 1.0; other reaetivities were 
determined relative to thymocytes. Measurements using the parallel line method in the spleen 
weight assay employed standard procedures for bioassay (16, 17). Measurements using the 
parallel line method in the mortality assay used the number of cells producing 50% mortality. 
The minimum number of cells resulting in a spleen index of 1.3 was regarded as the limiting 
dilution for that population in the spleen weight assay (4). The minimum number of cells 
causing 15% cumulative mortality was used as the limiting dilution for that population in 
the mortality  assay. 
synergy was not observed in this assay when either of the populations of cells 
allogeneic to the host was replaced by an equivalent population syngeneic with 
the host. 
Comparison  of the  Relative  Reactivities  of Cell Populations  in  the Mortality 
Assay with their Reactivities  in the Spleen  Weight Assay.--Parallel line assays 
have  been  employed  previously  (1-3,  R.  T.,  unpublished  observations)  to 
quantitatively compare the GVH reactivities, as judged by the spleen weight 
assay, of the same cell populations and the same strain combinations used in 
the present study. With the establishment of another set of parallel lines in this 
mortality assay (Fig. 3), it became possible to compare the relative reactivity 
of a given cell population in the two assays. The results of this comparison are 
shown in Table I. Thymocytes, the least reactive cell population in both assays, 
have arbitrarily been assigned an activity value of 1.0  in each assay, and the 
other tissues a figure corresponding to their reactivities relative to thymocytes. 1066  SYNERGY  IN  A  GVII  MORTALITY  ASSAY 
A value of 2 would indicate that the population was twice as reactive as thymo- 
cytes. The limiting dilution (the lowest number of cells necessary to observe a 
significant effect) for thymocytes was essentially the same in both assays, i.e., 
approximately 7 >( 106 cells. The rank order of reactivity from lowest to highest 
of thymus, spleen, femoral lymph node, and PBL was the same in the mortality 
assay as in the spleen weight assay. Quantitatively, however, it can be seen that 
spleen cells were more than  twice as  effective in causing splenomegaly (7.6) 
than they were in causing mortality (3.3). The opposite effect was observed for 
femoral lymph node cells, which were about 1.5 times as active as judged by the 
mortality assay as when judged by the spleen weight assay.  PBL, the most 
active cell population, also tended to show a higher reactivity in the mortality 
assay than in the spleen weight assay. The value of 25 for PBL in the spleen 
weight assay and of 31.3 in the mortality assay are averages, since these ratios 
relative to thymocytes varied slightly with the position on the dose-response 
curve at which the comparison was made. A similar analysis can be done using 
limiting dilutions, i.e., the smallest number of cells needed to produce a detect- 
able reaction. The results obtained by this method are almost the same as those 
obtained by the parallel line method. Thus, although the rank order  of tissue 
reactivities was the same in both GVH assays, spleen cells were relatively less 
active and PBL and femoral lymph node cells relatively more active in leading 
to death than they were in producing  splenomegaly. 
DISCUSSION 
The use of a mortality assay as a means of measuring the efficacy of various 
cell populations to provoke GVH reactions has been known for many years (4). 
In general, however, its use has been limited by a relative lack of sensitivity, 
particularly when normal adult F1 recipients are used. Relatively larger numbers 
of cells must be given in order to see significant mortality as compared  to the 
numbers required to give rise to significant splenomegaly (18). Furthermore, 
rather large increments in numbers of allogeneic lymphoid cells inoculated may 
produce little or no increase in mortality (reference 13,  also see Fig.  1). Pre- 
treatment of adult  F~  recipients with  sublethal  irradiation  (11,  19)  or cyclo- 
phosphamide  (12)  dramatically increases the sensitivity of these mice to the 
lethal effects of inoculation of parental strain ceils.  The reason(s) for this in- 
creased susceptibility to lethal GVH reactions is  (are)  not fully understood, 
and the present experiments did not address themselves to that question. How- 
ever, a  similar increase in sensitivity was noted in this  study  when  neonatal 
F1 mice were exposed to 400 R  whole body irradiation before inoculation of 
parental strain cells. Many fewer parental spleen cells were required to produce 
given levels of cumulative mortality in  irradiated  recipients than  in normal 
recipients.  Although  irradiation  alone did  not  produce significant mortality, 
such  pretreatment  increased  the  susceptibility  of the  recipients to  parental 
cells so that essentiallv 100% 35 day mortality was observed with a sufficient ROBERT  E.  TIGELAAR AND  RICKARD  ASOFSK¥  1067 
number  of lymphoid cells from any of  the  sources examined  in  this  study. 
Furthermore, the limiting dilutions in this mortality assay are of the same order 
of magnitude as those seen when one uses splenomegaly as the assay of the 
GVH reaction. 
The major purpose of these experiments was to determine whether the inocu- 
lation of mixtures of parental thymocytes and PBL would lead to lethal GVH 
reactions in more animals than would be predicted if the activities of these cell 
populations when mixed were merely the sum of the reactivities measured sepa- 
rately, i.e., whether synergy could be seen. Such synergy had been observed 
when GVH reactions were quantitated by a spleen weight assay (1-3). These 
observations have been explained by postulating a requirement for the presence 
of at least two cell populations for optimal expression of GVH reactivity. The 
two cell populations have been shown  to have the following characteristics: 
(a) One population is present in high concentrations in the pool of recirculating 
lymphocytes; the second is a population of relatively sessile cells found in high 
concentrations in thymus and spleen (2, 3). (b) Both populations must have the 
capacity to recognize the host as foreign (1-3).  (c)  Both of the cell types in- 
volved in this interaction are "thymic dependent" (2, 3, 20). (d) The cell type 
present in  excess in  thymocyte suspensions  appears to act as a  precursor of 
cells which inflict immunologic injury while the cell present in excess in PBL 
amplifies the activity of the former (2, 3). 
The present  studies  confirm and  extend previous observations  to  another 
quantitative assay of GVH reactions. Inoculation of 10 X  106 thymocytes with 
as few as 1.0 X  105 PBL resulted in 35 day cumulative mortality in excess of 
that expected from the separate reactivities of the constituent cells.  The ob- 
served reactivity of this combination was equivalent to that seen with 25 X  l0  t 
thymocytes alone, or nearly twice the expected reactivity. The limiting number 
of either population which can be used to give increased reactivity in this assay 
has not yet been determined, but preliminary experiments employing mixtures 
of 5.0 X  106 thymocytes and 1.0  X  105 PBL have clearly resulted in levels of 
mortality which show synergy. As in the spleen weight assay, the substitution 
in the mixture of thyrnocytes and PBL of syngeneic cells for either parental 
strain cell type resulted in cumulative 35 day mortalities similar to those seen 
with the one parental cell type alone. Therefore, both cell populations must be 
specifically reactive against the host to produce synergy. 
In  addition  to displaying characteristic quantitative  relationships  to  each 
other in  abilities  to cause a  given level of 35  day mortality,  the  peripheral 
lymphoid tissues also differed noticeably from thymocytes with respect to the 
average survival time of recipients which eventually died. Recipients of thymo- 
cytes survived approximately a week longer than did recipients of equivalently 
lethal numbers of PBL, lymph node, or spleen cells. The addition of 1.0 X  105 
PBL to 10 X  106 thymocytes, which resulted in markedly enhanced levels of 
35 day mortality, did not noticeably shorten the average survival time. It is 1068  SYNERGY  IN  A  GVH  MORTALITY  ASSAY 
possible that this assay system is not sensitive enough to detect the potentially 
subtle alteration in kinetics which could occur with the addition of small num- 
bers of PBL to thymocytes. On the other hand,  the fact that the kinetics ob- 
served for this combination were similar to those seen with thymocytes alone 
correlates well with the conclusion drawn from previous experiments (2, 3) that 
a  thymocyte is acting  as the precursor of the  effector cell while a  cell  in the 
PBL  suspension  is  acting  to amplify the  activity of a  cell in  the  thymocyte 
suspension.  It is also very likely that  the  cell interactions which  produce  in- 
creased mortality occur among different classes of thymus-derived cells, as is 
the case in the production of splenomegaly (20). 
Since the mortality assay and the spleen weight assay have been shown t9 
yield  sets of parallel  lines  of reactivities  for different  numbers  of  cells  from 
various sources,  it  is possible to compare quantitatively the relative activity 
of a given cell population in the two separate assay systems. The rank order of 
reactivity for the various tissues  tested was the same in both assays,  i.e.,  in 
order of decreasing effectiveness PBL, femoral lymph node, spleen, and thymus. 
When reactivity was expressed relative to the reactivity of thymocytes, femoral 
lymph node cells and PBL were much more active in the mortality assay than 
in the spleen weight assay, while spleen cells were nearly twice as effective in 
causing  splenomegaly in  Ft  recipients  as  the)" were  in  causing  death.  These 
findings are compatible with  the observations of Billingham and  Silvers (13) 
and  Cantor  et  al.  (14)  showing  that femoral lymph node  cells were particu- 
larly effective compared to spleen cells in causing early and subsequently lethal 
runting  in neonatal  recipients.  This effectiveness was not matched by similar 
effectiveness  in  causing  splenomegaly  in  such  recipients.  It  is  difficult  to 
ascribe such  quantitative differences in relative reactivities in  the two assays 
to  a  difference  in  the  sensitivities  of  the  assay  systems,  since  it  would  be 
expected that  such  a  difference in  sensitivity would  be reflected equally and 
and in the same direction for all cell populations tested. 
It is now clear that in some cases the optimal expression of GVH reactivity 
depends  on an interaction  between  at  least two  thymus-derived cells,  one of 
which is the precursor of the ultimate effector cell,  the other of which amplifies 
the activity of the first. Since this  establishes a  precedent for the  involvement 
of more than one type of thymus-derived lymphoid cell ia a  cellular immune 
reaction, it is possible that different effector functions, in this case the abilities 
to produce  either  death  or splenomegaly, involve distinct  types of precursor 
cells. 
SUMMARY 
A mortality assay was used to quantitate graft-versus-host  (GVH) reactions 
insublethallyirradiated (400 R)neonatal  (C57BL/6  X  BALB/c)F1 recipients 
of  BALB/c  lymphoid  cells  from  various  tissues.  The  probit  of  the  35  day 
cumulative per cent of mortality was a linear function of the logarithm of the ROBERT E.  TIGELAAR  AND RICHARD ASOFSKY  1069 
cell  inoculum for any tissue; reactivities of different tissues fell  on a  series of 
parallel  lines.  Peripheral blood leukocytes (PBL),  the most active cells,  were 
about 30 times as active as thymocytes, the least active cells studied; femoral 
lymph node cells  and  spleen  cells  were  about 23  and  8  times  as  reactive as 
thymocytes, respectively. The average survival time of recipients of thymocytes 
who eventually died was nearly a week longer than that of recipients of com- 
parably lethal numbers of PBL, lymph node, or spleen cells. 
Mixtures  of PBL and  thymocytes gave levels  of 35  day mortality signifi- 
cantly greater than those expected if the reactivities of the  mixture  had been 
merely  the  sum  of  the  reactivities  of  the  components measured  separately, 
thereby confirming in any assay independent of host splenomegaly the syner- 
gistic interaction of thymocytes and PBL in the GVH reaction. Both popula- 
tions of cells in the mixture had to be allogeneic to the host in order to observe 
this synergy. 
The  kinetics  of  cumulative  mortality  observed  for  mixtures  of  PBL  and 
thymocytes were  indistinguishable  from  those  seen  with  thymocytes alone, 
indicating activation of the latter cell type. Finally, comparison of the relative 
abilities of different cell populations to cause splenomegaly on the one hand and 
lethal runting on the other has raised the possibility that expression of different 
effector functions of cell-mediated immune reactions may in fact be  initiated 
by distinct cells. 
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